Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

Jean-Guillaume Letarouilly, PhD, MD

CHU Lille
Lille, France

Associates Professor at Lille University Hospital
His research interests focus on axial spondyloarthritis,
psoriatic arthritis, and the crosstalk between inflammatory bowel diseases and psoriasis. He is a member of the Emeunet's Visibility and Global Affairs Subcommittee and of the Young GRAPPIAN
Subcommittee.

Presentation(s):

  • 0572: Real-World Treat-to-Target Strategy in Psoriatic Arthritis: 48-week Results from the MONITOR-PsA Cohort

    Sunday, October 26, 2025
    10:30 AM - 12:30 PM Central Time

    Disclosure(s): AbbVie/Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, August 3, 2025); Alfasigma: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, August 3, 2025); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 30, 2025); Biogen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, August 3, 2025); Bristol-Myers Squibb(BMS): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, May 4, 2025); Celltrion: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 13, 2025); Eli Lilly: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 7, 2025); Janssen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, August 3, 2025); Merck/MSD: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 8, 2024); Nordic Pharma: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, June 1, 2025); Novartis: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, July 6, 2025); Pfizer: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); UCB: Officer or Board Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)